These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
835 related items for PubMed ID: 9003010
1. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts. Takahashi Y, Tobe K, Kadowaki H, Katsumata D, Fukushima Y, Yazaki Y, Akanuma Y, Kadowaki T. Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010 [Abstract] [Full Text] [Related]
2. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Guvakova MA, Surmacz E. Cancer Res; 1997 Jul 01; 57(13):2606-10. PubMed ID: 9205064 [Abstract] [Full Text] [Related]
3. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Sasaoka T, Ishiki M, Sawa T, Ishihara H, Takata Y, Imamura T, Usui I, Olefsky JM, Kobayashi M. Endocrinology; 1996 Oct 01; 137(10):4427-34. PubMed ID: 8828504 [Abstract] [Full Text] [Related]
12. Insulin growth factor-I and epidermal growth factor receptors recruit distinct upstream signaling molecules to enhance AKT activation in mammary epithelial cells. Fleming JM, Desury G, Polanco TA, Cohick WS. Endocrinology; 2006 Dec 01; 147(12):6027-35. PubMed ID: 16990343 [Abstract] [Full Text] [Related]
13. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway. Kurihara S, Hakuno F, Takahashi S. Endocr J; 2000 Dec 01; 47(6):739-51. PubMed ID: 11228049 [Abstract] [Full Text] [Related]
14. Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors. Ishihara H, Sasaoka T, Ishiki M, Takata Y, Imamura T, Usui I, Langlois WJ, Sawa T, Kobayashi M. J Biol Chem; 1997 Apr 04; 272(14):9581-6. PubMed ID: 9083103 [Abstract] [Full Text] [Related]
15. Relative involvement of Shc tyrosine 239/240 and tyrosine 317 on insulin induced mitogenic signaling in rat1 fibroblasts expressing insulin receptors. Ishihara H, Sasaoka T, Wada T, Ishiki M, Haruta T, Usui I, Iwata M, Takano A, Uno T, Ueno E, Kobayashi M. Biochem Biophys Res Commun; 1998 Nov 09; 252(1):139-44. PubMed ID: 9813159 [Abstract] [Full Text] [Related]
16. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner. Sasaoka T, Ishihara H, Sawa T, Ishiki M, Morioka H, Imamura T, Usui I, Takata Y, Kobayashi M. J Biol Chem; 1996 Aug 16; 271(33):20082-7. PubMed ID: 8702728 [Abstract] [Full Text] [Related]
17. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts. Takahashi Y, Akanuma Y, Yazaki Y, Kadowaki T. J Cell Physiol; 1999 Jan 16; 178(1):69-75. PubMed ID: 9886492 [Abstract] [Full Text] [Related]
18. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells. Morrione A, Romano G, Navarro M, Reiss K, Valentinis B, Dews M, Eves E, Rosner MR, Baserga R. Cancer Res; 2000 Apr 15; 60(8):2263-72. PubMed ID: 10786694 [Abstract] [Full Text] [Related]
19. Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors. Inoue G, Cheatham B, Kahn CR. J Biol Chem; 1996 Nov 08; 271(45):28206-11. PubMed ID: 8910437 [Abstract] [Full Text] [Related]
20. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells. Ariga M, Nedachi T, Akahori M, Sakamoto H, Ito Y, Hakuno F, Takahashi S. Biochem J; 2000 Jun 01; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436 [Abstract] [Full Text] [Related] Page: [Next] [New Search]